Cargando…
Cell augmentation strategies for cardiac stem cell therapies
Myocardial infarction (MI) has been the primary cause of death in developed countries, resulting in a major psychological and financial burden for society. Current treatments for acute MI are directed toward rapid restoration of perfusion to limit damage to the myocardium, rather than promoting tiss...
Autores principales: | Cruz‐Samperio, Raquel, Jordan, Millie, Perriman, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133336/ https://www.ncbi.nlm.nih.gov/pubmed/33660953 http://dx.doi.org/10.1002/sctm.20-0489 |
Ejemplares similares
-
Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies
por: Ekblad‐Nordberg, Åsa, et al.
Publicado: (2019) -
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
por: Weng, Zhijie, et al.
Publicado: (2022) -
Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
por: Arias, Jonathan, et al.
Publicado: (2021) -
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
The emerging antioxidant paradigm of mesenchymal stem cell therapy
por: Stavely, Rhian, et al.
Publicado: (2020)